Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ADRIANA STRUTT and MICHELE YORK.
ADRIANA STRUTT
Connection Strength
3.565
MICHELE YORK
  1. Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis. ISRN Neurol. 2012; 2012:912123.
    View in: PubMed
    Score: 0.422
  2. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011 Oct; 25(7):1253-65.
    View in: PubMed
    Score: 0.399
  3. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7.
    View in: PubMed
    Score: 0.391
  4. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8.
    View in: PubMed
    Score: 0.317
  5. Developing a Culturally Competent Neuropsychological Battery for Diagnosis of Dementia in Arabic-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):433-445.
    View in: PubMed
    Score: 0.223
  6. A Neuropsychological Battery for the Evaluation of Dementia Among Mandarin-Speaking Older Adults in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):446-458.
    View in: PubMed
    Score: 0.223
  7. Culturally Competent Approaches for Neuropsychological Assessment for Differential Diagnosis of Dementia of Korean-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):459-471.
    View in: PubMed
    Score: 0.223
  8. Developing a Culturally Competent Neuropsychological Assessment Battery for Vietnamese-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):485-500.
    View in: PubMed
    Score: 0.223
  9. Developing Culturally Competent Foreign Language Neuropsychological Assessments: Portuguese-Speaking Brazilians Living in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):501-512.
    View in: PubMed
    Score: 0.223
  10. Screening for Neurocognitive Impairment in HIV Individuals: The Utility of the Montreal Cognitive Assessment Test. J AIDS Clin Res. 2012 Dec; 3(10):186.
    View in: PubMed
    Score: 0.108
  11. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012 Aug; 27(5):545-56.
    View in: PubMed
    Score: 0.105
  12. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31.
    View in: PubMed
    Score: 0.105
  13. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7.
    View in: PubMed
    Score: 0.096
  14. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22.
    View in: PubMed
    Score: 0.090
  15. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63.
    View in: PubMed
    Score: 0.077
  16. Geopolitical Considerations for Working with Medically Complex Patients: A Case Illustration. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):387-394.
    View in: PubMed
    Score: 0.056
  17. Developing a Culturally Competent Neuropsychological Assessment Battery for Farsi-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):472-484.
    View in: PubMed
    Score: 0.056
  18. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):692-695.
    View in: PubMed
    Score: 0.039
  19. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015 Aug 24; 29(13):1711-4.
    View in: PubMed
    Score: 0.033
  20. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24.
    View in: PubMed
    Score: 0.023
  21. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8.
    View in: PubMed
    Score: 0.023
  22. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010 Jul; 112(6):544-7.
    View in: PubMed
    Score: 0.023
  23. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 03; 11(3):303-11.
    View in: PubMed
    Score: 0.023
  24. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010; 29(1):28-36.
    View in: PubMed
    Score: 0.022
  25. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9.
    View in: PubMed
    Score: 0.022
  26. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009; 28(2):145-52.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.